openPR Logo
Press release

Research Antibodies Market to Witness Sales Slump in Near Term Due to COVID-19 Long-term Outlook Remains Positive

09-25-2020 07:01 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Report And Data

Research Antibodies Market

Research Antibodies Market

Reports and Data have released a new market report titled “Global Research Antibodies Market” which is an extensive study of the Research Antibodies market spanning over 100+ pages with pictorial representations of key statistical data. The report on the Research Antibodies market offers a complete examination of the market and contains key data on the current and emerging trends, growth factors, facts, and other key elements. The report offers market forecast estimation for the global Research Antibodies market till 2027. Furthermore, it offers insights into the market dynamics and competitive landscape to offer readers key information to capitalize on market trends.

Additionally, this report is the latest report covering the impact analysis of the COVID-19 pandemic on the Research Antibodies market. It is furnished with key statistical data regarding the effect of the pandemic on the supply chain and economic scenario of the market. The study also covers the changes in market dynamics and trends and offers a futuristic perspective in a post-COVID-19 scenario. The report also encompasses an initial and future assessment of the impact of the global health crisis on the industry.

Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/3270

The global Research Antibodies market was valued at USD 3.35 Billion in 2019 and is anticipated to register a CAGR of 5.9%to garner a valuation of USD 5.33 Billion by the end of 2027. The study considers 2017-2018 as historical years, 2019 as the base year, and 2020-2027 as forecast years to estimate the market share and size of the Research Antibodies market. The report covers the Research Antibodies market on a global scale along with market breakdown into product types, applications, technology, end-user, and key regions.

Increased funding for research and development activities is instrumental in driving the growth of the market. Investment in the healthcare R&D by the US has witnessed a growth of 18.1% between the years 2014 and 2017. In the year 2017, in the US, the overall expenditure on healthcare R&D was USD 182.30 billion. Besides, according to the 2016 financial statements of Celgene Corporation, a leading biopharmaceutical firm, the R&D expenditure grew by USD 772.8 million (21.0% more than 2015 expenses) in 2016 to USD 4.47 billion. Also, a USD 892.9 million of R&D asset acquisition spending, comprising a USD 625.0 million purchase of Engmab AG, a private firm engaged in T-cell bispecific antibodies, added to the overall R&D expenses of the Celgene.

Request a discount on the report @ https://www.reportsanddata.com/discount-enquiry-form/3270

Competitive Analysis:

The report covers extensive analysis of the competitive landscape and offers key insights into the prominent players operating in the industry. The key players are committed to innovations and advancements in product and technological developments and formulate strategic investment plans. The profiles of key companies such as Becton, Dickinson and Company, Lonza Group, Agilent Technologies, Abcam PLC, PerkinElmer, Inc., Bio-Rad Laboratories, Merck Millipore, F.Hoffmann-La Roche AG, Thermo Fisher Scientific, and Cell Signaling Technology Inc., among others are covered in the report and offers basic information, company overview, m-cap valuations, profit margins, global reach and position, financial standing, and market share, among others.

Along with this, the report also offers detailed segmentation of the market based on types and applications.

Product Outlook (Revenue, USD Million; 2017-2027)

Primary Antibodies
Secondary Antibodies

Antibody Type Outlook (Revenue, USD Million; 2017-2027)

Monoclonal
Polyclonal

Technology Outlook (Revenue, USD Million; 2017-2027)

Western Blotting
Flow Cytometry
Immunofluorescence
Immunohistochemistry
Enzyme-linked Immunosorbent Assay
Immunoprecipitation
Others

Application Outlook (Revenue, USD Million; 2017-2027)

Oncology
Infectious Diseases
Stem Cells
Neurobiology
Immunology
Others

Industry Vertical Outlook (Revenue, USD Million; 2017-2027)

Pharmaceutical & Biopharmaceutical
Academic & Research Institutes
Contract Research Organizations

Key features of the Report:

Identification of key factors influencing the market growth
Insightful information regarding market opportunities and market scenarios to give a competitive edge to the companies
SWOT analysis and Porter’s Five Forces analysis to offer comprehensive competitive data
Analysis of regions that are expected to witness significant growth during the forecast period
Risk and challenge assessment to offer strategic recommendations to the established companies and new entrants
Comprehensive competitive analysis and regional analysis
Market dynamics along with trends and demand patterns
Market segmentation analysis along with product types, application spectrum, and end-user industry, along with their expected growth in the forecast period

To know more about the report, click @ https://www.reportsanddata.com/report-detail/research-antibodies-market

To understand the dynamics of the global Research Antibodies market, the industry is analyzed over the key geographical regions.

These key regions of the world include:

North America(U.S., Canada)
Europe(U.K., Italy, Germany, France, Rest of EU)
AsiaPacific(India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America(Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa(Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Thank you for reading this report. Customization of this report is available based on regions and specific chapters. Please get in touch with us if you have any queries, and our team will ensure the report is well-suited to meet your requirements.

40 Wall St. 28th floor New York City, NY 10005 United States

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Research Antibodies Market to Witness Sales Slump in Near Term Due to COVID-19 Long-term Outlook Remains Positive here

News-ID: 2143319 • Views:

More Releases from Report And Data

Automotive On-Board AC/DC Power Inverters Market to Reach USD 3.9 Billion by 2034, Driven by EV Demand and Smart Vehicle Technologies
Automotive On-Board AC/DC Power Inverters Market to Reach USD 3.9 Billion by 203 …
The global Automotive On-Board AC/DC Power Inverters Market is projected to grow from USD 1.2 billion in 2024 to USD 3.9 billion by 2034, expanding at a strong CAGR of 12.70%, according to the latest industry analysis. This rapid growth is being fueled by the rising adoption of electric vehicles (EVs), advancements in in-car electronics, and the growing need for power solutions in modern vehicles. To avail Sample Copy of the
Global Automotive Cabin Insulation Market to Reach USD 4.7 Billion by 2034, Driven by Demand for Comfort, Efficiency, and Sustainability
Global Automotive Cabin Insulation Market to Reach USD 4.7 Billion by 2034, Driv …
The global Automotive Cabin Insulation Market is on a strong growth trajectory, projected to rise from USD 2.0 billion in 2024 to USD 4.7 billion by 2034, growing at a CAGR of 8.7%, according to a new industry report. The growth is fueled by rising consumer expectations for quieter, more comfortable vehicles and increasing focus on energy efficiency and environmental standards. To avail Sample Copy of the report @ https://www.reportsanddata.com/sample-enquiry-form/19439 Comfort and
Automotive 48V Systems Market Size: 2034 Statistics
Automotive 48V Systems Market Size: 2034 Statistics
The global Automotive 48V Systems Market is poised for strong growth, expected to rise from USD 1.8 billion in 2024 to USD 5.3 billion by 2034. This represents a healthy annual growth rate of nearly 11%, fueled by rising demand for fuel-efficient vehicles, tighter emissions regulations, and the push toward vehicle electrification. Mild hybrid vehicles lead the market today, offering a practical way for automakers to cut emissions while improving fuel
3D Printing Automotive Market to Soar from $3.36 Billion in 2024 to $25.61 Billion by 2034
3D Printing Automotive Market to Soar from $3.36 Billion in 2024 to $25.61 Billi …
The global 3D printing automotive market is set for remarkable growth, projected to rise from USD 3.36 billion in 2024 to USD 25.61 billion by 2034, with an impressive annual growth rate of 22.53%. This growth is driven by the rising use of 3D printing for faster prototyping, efficient production, and reduced material waste across the automotive industry. Prototyping is currently the largest application of 3D printing in automobiles, helping manufacturers

All 5 Releases


More Releases for Antibodies

Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Key Trend Reshaping the Biosimilar Monoclonal Antibodies Market in 2025: Advance …
What Are the Projections for the Size and Growth Rate of the Biosimilar Monoclonal Antibodies Market? In recent times, the biosimilar monoclonal antibodies sector has experienced a swift expansion. The market size, which stands at $8.04 billion in 2024, is projected to climb to $9.25 billion in 2025, marking a compound annual growth rate (CAGR) of 15.1%. Factors such as expired patents, an increased understanding of biosimilars, governmental strategies, heightened financial
Arthritis Monoclonal Antibodies Market Report 2024 - Arthritis Monoclonal Antibo …
"The Business Research Company recently released a comprehensive report on the Global Arthritis Monoclonal Antibodies Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. According to The Business Research Company's, The arthritis monoclonal antibodies
Global Multispecific Antibodies Market Size Antibodies Sales Forecast 2029
Global Multispecific Antibodies Market, Drug Sales, Price & Clinical Trials Insight 2029 Report Highlights: • Global & Regional Market Analysis • Global Multispecific Antibodies Market Opportunity: > USD 40 Billion • Global Multispecific Antibodies Market Sales In 2023: > USD 8 Billion • Number Of Approved Multispecific Antibodies: 14 • Approved Antibodies Global, Regional, Annual & Quarterly Sales Insight • Approved Antibodies Dosage & Pricing Insight • Number Of Multispecific Antibodies: In Clinical Trials: > 900 • Comprehensive Insight On All Antibodies In Clinical Trials By
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: • Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms • Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023) • Global Bispecific Antibodies Market Size 2023: > USD 8 Billion • Global Bispecific Antibodies Market Forecast Till 2029 • Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023) • Approved Bispecific Antibodies Regional Sales (2018 till 2023) • Clinical and Commercial Insight On Approved
Emergence of Tetravalent Antibodies
The emergence of tetravalent antibodies represents a significant advancement in the field of therapeutic antibodies, offering new possibilities for treating complex diseases such as cancer, infectious diseases, and autoimmune disorders. These innovative molecules, capable of binding to four antigens or epitopes simultaneously, provide enhanced specificity, efficacy, and versatility, addressing the limitations of traditional monoclonal and even bispecific antibodies. Download Bispecific, Trispecific and Tetraspecific Antibodies Report: https://www.kuickresearch.com/ccformF.php?t=1721642510 Tetravalent antibodies are designed to engage